• About Amgen
  • Science
  • Corporate Giving
  • Site Map
  • Search
  • Privacy & Terms
  • Contact Us
Amgen
  • Patients
  • Medical Professionals
  • Partners
  • Investors
  • Careers
  • Media
  • print
  • mail
  • Home
  • Media
  • In the News
  • EnbrelŪ in the News

  • Overview
  • Fact Sheets
  • Featured Content
  • Press Releases
  • Media Contacts
  • In the News
  • ESAs in the News
  • EnbrelŪ in the News
  • Pipeline in the News
  • Virtual Press Kits
In the News
Enbrel® (etanercept) in the News
Jun. 18, 2008
Amgen and Wyeth Statement on Outcome of Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Jun. 18, 2008
Enbrel® (etanercept) Application for the Treatment of Pediatric Psoriasis to be Discussed at FDA Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting
Jun. 16, 2008
Amgen Statement on Briefing Materials Prepared for June 18, 2008 DODAC Meeting
Jun. 4, 2008
Amgen and Wyeth Statement on the FDA Early Communication About Tumor Necrosis Factor (TNF) Blockers
May 1, 2008
Amgen to Participate in Dermatologic and Ophthalmic Drugs Advisory Committee Meeting in June
Apr. 16, 2008
Amgen Statement on Alzheimer's Case Study
Mar. 17, 2008
Press Release: Amgen Announces Update to U.S. Prescribing Information for Enbrel®
Mar. 17, 2008
Letter to Healthcare Professionals

Background Documents

Prescribing information for Enbrel®

 


  • Related Links
  • Products
  • Pipeline
  • Stock Info
  • Corporate Citizenship
  • Locations
footer